Impact of ATP-binding cassette, subfamily B, member 1 pharmacogenetics on tacrolimus-associated nephrotoxicity and dosage requirements in paediatric patients with liver transplant. [electronic resource]
- Expert opinion on drug safety Jan 2011
- 9-22 p. digital
Publication Type: Journal Article; Review
1744-764X
10.1517/14740338.2010.505600 doi
ATP Binding Cassette Transporter, Subfamily B ATP Binding Cassette Transporter, Subfamily B, Member 1--biosynthesis Animals Child Humans Immunosuppressive Agents--administration & dosage Kidney Diseases--chemically induced Liver Transplantation Pharmacogenetics--methods Polymorphism, Genetic Tacrolimus--administration & dosage